维普中文期刊产品整合服务
83篇 您的检索式:作者名="Dluzen"
    题名 作者 年代 出处 被引量
1Oestrogen and nigrostriatal dopaminergic neurodegeneration : animal models and clinical reports of Parkinson' s disease 显示文摘Liu B Dluzen DE 2007Clin Exp Pharmacol Physiol2007,34,7:1
2Neuroprotec tire actions of sex steroids in Parkinson's disease显示文摘BOURQUE M DLUZEN D E DI PAOLO T 2009Front Neuroendocrinol2009,30,2:1
3Oestrogen and nigrostriatal dopaminer-gicneurodegeneration ; animal models and clinical reportsof Parkinson5 s disease 显示文摘Liu B Dluzen DE 2007Clin Exp Pharmacol Physiol2007,34,7:1
4Oestrogen and nigrostriatal dopaminergic neurodegeneration:animal models and clinical reports of Parkinson's disease显示文摘Liu B Dluzen DE 0,,7:1
5Age-related changes in nigrostriatal dopaminergic function are accentuated in +/-brain-derived neurotrophic factor mice显示文摘Dluzen DE Mcdermott JL Anderson LI 2004Neuroscience2004,128,:1
6Estrogen,testosterone,and methamphetamine toxicity 显示文摘Dluzen D E McDermott J L 2006Ann N Y Acad Sci2006,1074,:1
7Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release 显示文摘Disshon K A Dluzen D E 1997Brain Res1997,764,12:1
8Bcl-2 is a downstream target of ATF5 that mediates ATF5' pro-survival function in a cell type-dependent manner显示文摘Dluzen D Li G Tacelosky D 2011Biol Chem2011,286,9:1
9Gender differences in methamphetamine useand responses : a review 显示文摘Dluzen DE Liu B 2008Gend Med2008,5,1:1
10Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells显示文摘Li N Liu B Dluzen D E 2007J Ethnopharmaco12007,111,3:1
11Structure–activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B显示文摘Richard T. Carroll Dean E. Dluzen Hilary Stinnett Prabha S. Awale Max O. Funk Werner J. Geldenhuys 2011Bioorganic & Medicinal Chemistry Letters2011,,16:1
12Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system显示文摘Dluzen DE 2000J Neurocytol2000,29,56:1
13Gender differences in neurotoxicity of the nigrostriatal dopaminergic system:implications for Parkinson’s disease显示文摘Dluzen DE McDermott JL 2000J Gend Specif Med2000,3,6:1
14Alteration of dopamine release by rat caudate putamen tissues superfused with alpha 2-macroglobulin 显示文摘Hu YQ Liu B J Dluzen DE 1996J Neurosci Res1996,43,1:1
15Oestrogen and nigrostriatal dopaminergic neurodegeneration:animal models and clinical reports of Parkinson's disease显示文摘Liu B Dluzen DE 2007Clin Exp Pharmacol Physiol2007,34,7:1
16Neuroprotective actions of sex Steroids in Parkinson's disease 显示文摘Bourque M Dluzen D E Di Paolo T 2009Front Neuroendcriol2009,30,2:1
17Regulation of UDP- glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p显示文摘Dluzen D F Sun D X Salzberg A C 2014J Pharmacol Exp Ther2014,348,3:1
18Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system显示文摘Dluzen DE 2000Neurocytol2000,29,56:1
19Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells 显示文摘LI N LIU B DLUZEN DE 2007J Ethnopharmacol2007,111,3:1
20Estrogen and Parkinson's disease 显示文摘Horstink MW Strijks E Dluzen DE 2003Adv Neurol2003,91,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费